tirzepatide weight loss clinical trial results Semaglutide vs Tirzepatide: Which GLP-1 Wins for Loss? How Tirzepatide Helped A 24

Journal of Nanobiotechnology 19(1):118

With repeated dosing, mean IGF-1 levels remained above baseline for up to 28 days

Maintaining a balanced diet and a consistent meal schedule supports the medications effectiveness

Cardiometabolic markers were projected to return to pre-treatment levels within ~1.4 years post-cessation

In 2016, 650 million people were obese and in 2020, 39 million children under the age of 5 were already overweight or obese ( Current guidelines for the treatment of diabetes and obesity recommend a step-wise approach starting with lifestyle interventions aimed at body weight loss, an increase in physical activity, and additional measures for healthier choices in everyday decisions and habits